Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ezerra is a topical skincare product line formulated primarily to relieve symptoms of dry, itchy, and irritated skin associated with conditions such as atopic dermatitis. It features a unique multi-action formulation that provides intense moisturization while protecting the skin from bacteria and external irritants. The key active ingredient is Stimutex-AS, a naturally-derived blend of spent grain wax, argan oil, and shea butter that helps soothe sensitive skin by relieving itchiness and irritation. Additional ingredients include tripeptide for skin health protection, saccharide isomerate as a natural humectant for hydration, and SK-influx V (a ceramide-rich lipid) to replenish moisture. The products are fragrance-free and safe for use on babies as young as two weeks old. Ezerra products are developed with an emphasis on natural ingredients without parabens, phthalates, SLS/SLES preservatives or fragrances.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ezerra.